 | Up a level |
Martinello, Marianne; Carson, Joanne M; Van Der Valk, Marc; Rockstroh, Jürgen K; Ingiliz, Patrick; Hellard, Margaret; Nelson, Mark; Lutz, Thomas; Bhagani, Sanjay; Kim, Arthur Y; Hull, Mark; Cordes, Christiane; Moon, Juhi; Feld, Jordan J; Gane, Ed; Rauch, Andri; Bruneau, Julie; Tu, Elise; Applegate, Tanya; Grebely, Jason; ... (2023). Reinfection incidence and risk among people treated for recent hepatitis C virus infection: the react study. AIDS, 37(12), pp. 1883-1890. Wolters Kluwer Health 10.1097/QAD.0000000000003651
Carson, Joanne M; Barbieri, Sebastiano; Cunningham, Evan; Mao, Eric; van der Valk, Marc; Rockstroh, Jürgen K; Hellard, Margaret; Kim, Arthur; Bhagani, Sanjay; Feld, Jordan J; Gane, Ed; Thurnheer, Maria C; Bruneau, Julie; Tu, Elise; Dore, Gregory J; Matthews, Gail V; Martinello, Marianne (2023). Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study. Journal of the International AIDS Society, 26(9), e26168. BioMed Central 10.1002/jia2.26168
Koopsen, Jelle; Matthews, Gail; Rockstroh, Juergen; Applegate, Tanya L; Bhagani, Sanjay; Rauch, Andri; Grebely, Jason; Sacks-Davis, Rachel; Ingiliz, Patrick; Boesecke, Christoph; Rebers, Sjoerd; Feld, Jordan; Bruneau, Julie; Martinello, Marianne; Hellard, Margaret; Dore, Gregory J; Schinkel, Janke; van der Valk, Marc (2023). Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis. The Lancet Microbe, 4(8), e622-e631. Elsevier 10.1016/S2666-5247(23)00108-8
Isfordink, Cas J; Boyd, Anders; Sacks-Davis, Rachel; van Santen, Daniela K; Smit, Colette; Martinello, Marianne; Stoove, Mark; Berenguer, Juan; Wittkop, Linda; Klein, Marina B; Rauch, Andri; Salmon, Dominique; Lacombe, Karine; Stewart, Ashleigh; Schinkel, Janke; Doyle, Joseph S; Hellard, Margaret; van der Valk, Marc; Matthews, Gail V (2023). Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. The lancet. Public health, 8(4), e294-e304. Elsevier 10.1016/S2468-2667(23)00056-7
Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056
